allogeneic anti-CD33 CAR T cells VCAR33
Term · Oncology and biomedicine · MLC-T-ONC-009818
A preparation of allogeneic T lymphocytes, derived from the same matched healthy donor who provided a stem cell transplant and transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) specific for the CD33 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, allogeneic anti-CD33 CAR T cells VCAR33 specifically recognize and kill CD33-expressing tumor cells. CD33 is expressed on normal non-pluripotent hematopoietic stem cells and is overexpressed on myeloid leukemia cells.
| Identifier | MLC-T-ONC-009818 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic anti-CD33 CAR-T cells VCAR33; donor-derived anti-CD33 CAR T cells VCAR33 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009818",
"term": "allogeneic anti-CD33 CAR T cells VCAR33",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic T lymphocytes, derived from the same matched healthy donor who provided a stem cell transplant and transduced with a lentiviral vector to express a chimeric antigen receptor (CAR) specific for the CD33 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, allogeneic anti-CD33 CAR T cells VCAR33 specifically recognize and kill CD33-expressing tumor cells. CD33 is expressed on normal non-pluripotent hematopoietic stem cells and is overexpressed on myeloid leukemia cells.",
"synonyms": [
"allogeneic anti-CD33 CAR-T cells VCAR33",
"donor-derived anti-CD33 CAR T cells VCAR33"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-anti-cd33-car-t-cells-vcar33/"
}
Record 703 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.